Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Meddevicetracker

Meddevicetracker's Real-time Device Market Data API Solution

19 Mar 2019

Bringing our trusted data to your systems – fast.

Topic Medtech

View infographic
Pharmaprojects

Pharma R&D Annual Review 2019

By Ian Lloyd 12 Mar 2019

Pharma R&D Annual Review 2019 is based on the stats and data from from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects.

Topic Clinical trials Diseases Research Drug approval Drug review

View white paper
Citeline, Sitetrove, Trialtrove, Pharmaprojects

Citeline: Global Clinical Trial Intelligence Solutions

12 Mar 2019

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Topic Clinical trials Clinical trial optimization

Single report
Primal Pictures

Primal Pictures: 3D Functional Anatomy

12 Mar 2019

Engage, Educate and Inspire. Promote mastery of functional anatomy in any learning, teaching or practice environment – faster, easier and more efficiently than ever before.

View infographic
Pharmaprojects

Pharma R&D Annual Review 2019 Infographic

By Ian Lloyd 12 Mar 2019

Get your head in the game with a free download of the Pharma R&D Annual Review 2019 infographic from Informa Pharma Intelligence. This year’s look at the key players and reigning champs of R&D uses a sports theme to present its critical data on the current state of pharma R&D.

Topic Research Drug development landscape Diseases Drug review

View infographic
Meddevicetracker

Meddevicetracker API Infographic

11 Mar 2019

Quickly assess the competitive landscape, identify partnership opportunities, and spot threats before they become a problem with data from Meddevicetracker’s new API solution. The Real-time Device Market Data API from Meddevicetracker gives you the power to search and stream vital information directly from Meddevicetracker into your internal software systems and embed Meddevicetracker’s high-quality, exclusive datasets directly into your own workflows.

View infographic
HBW Insight

With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives

By Malcolm Spicer 07 Mar 2019

Scott Gottlieb claimed higher profile than most previous FDA commissioners with frequent Twitter posts and by including his remarks in many agency communications to industries and consumers. In his nearly two years in post, he also had more central role in FDA initiatives in areas such as keeping unsafe products labeled as supplements off the market and explaining why hemp and CBD are available and supplements even though FDA considers the products noncompliant as dietary ingredients.

Topic FDA

View article
Medtech Insight

Drug-Coating Safety Risk Acknowledged At Cardiology Gathering, But Cause Remains Elusive

By Elizabeth Orr 07 Mar 2019

Physicians and researchers in an all-day session at the Cardiovascular Research Technologies conference in Washington, DC, on March 5 largely backed the recent finding that paclitaxel-coated balloons and stents may be tied to a higher patient mortality rate. But the specific mechanism underlying the deaths remains unknown.

Topic Medtech

View article
Scrip

Bayer Bosses Beg Risk-Averse Europe To Rethink

By Kevin Grogan 07 Mar 2019

The German group believes it is going to be at the forefront of development in the cell and gene therapy space but is worried that Europe is failing to recognize the value that the pharma industry and its new technologies can create for society.

Topic Cell and gene therapy

View article
Scrip

Asia Deal Watch: Bharat Expands Its Vaccine Holdings By Buying GSKs Chiron Behring

By Anju Ghangurde 07 Mar 2019

Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.

Topic Drug approval Business strategies

View article
HBW Insight

Targeted Omega-3 Supplementation Could Save Up To €64.5bn In Healthcare Costs, Food Supplements Europe Claims

By David Ridley 07 Mar 2019

A new position paper by Food Supplements Europe calculates the potential savings that targeted supplementation with omega-3, calcium, phytosterols and vitamins D and B9 could bring for cash-strapped European governments.

Topic Drug development landscape Drug review

View article
Medtech Insight

4C Medical Plans First Early Feasibility Study For An Implantable In Japan

By Elizabeth Orr 07 Mar 2019

4C Medical plans to conduct both an early feasibility study and the pivotal trial for its mitral regurgitation treatment device simultaneously in Japan, the US and Canada. The company says the study is the first early feasibility study in Japan for an implantable device.

Topic Medtech

View article
Generics Bulletin

Two New Categories Join GGB Awards In 2019

By David Wallace 07 Mar 2019

Two new categories – Value Added Medicine Of The Year and Legal Strategy Of The Year – have been added to the Global Generics & Biosimilars Awards in 2019, which will take place on 5 November in Frankfurt, Germany.

Topic BioPharmaceutical Biosimilars

View article
Generics Bulletin

US Bill Aims To Increase Transparency On Biologics

By David Wallace 07 Mar 2019

Several US senators have lent their backing to the draft Biologic Patent Transparency Act, as part of efforts to address “patent thickets” around brand biologics.

Topic BioPharmaceutical Drug approval Drug review

View article
Trialtrove

From STEP to PrEP

By Jonathan Slater 07 Mar 2019

In June 2016, all United Nations Member States pledged to end the AIDS epidemic as a public health threat by 2030 and signed up to time-bound targets.

Topic Drug development landscape Diseases

View infographic

Latest headlines

Medtech Insight

19 Mar 2019

Warning Letter Roundup & Recap – March 19, 2019

Link
Medtech Insight

19 Mar 2019

Hong Kong Clarifies Rules On Local Responsible Persons To Facilitate Device Listings

Link
Pink Sheet

19 Mar 2019

‘Keep Planning For No-Deal Brexit,’ UK Govt Tells Pharma As Chaos Grows

Link
Scrip

19 Mar 2019

Zulresso Is Sage’s First Step In Postpartum Depression Treatment

Link
Scrip

19 Mar 2019

Merck KGaA Interview: China E-Health Push A ‘Long-Term Strategy’

Link
Pink Sheet

19 Mar 2019

US FDA “Enriches” Trial Guidance With Recent Examples

Link
Scrip

19 Mar 2019

PureTech’s Karuna Gets Another $68m For Re-engineered Lilly CNS Candidate

Link
Medtech Insight

19 Mar 2019

EU MDR: Swiss Medtechs Count The Cost Of Being Without An MRA

Link
Pink Sheet

19 Mar 2019

AbbVie's 'Unjustified' Humira Settlements Divide Market, Class Action Claims

Link
Pink Sheet

19 Mar 2019

Gottlieb Touts US FDA's Organizational Structure For Advancing Policies During His Tenure

Link
Scrip

19 Mar 2019

Urovant’s Vibegron Faces Tough Commercial Climb Despite Phase III Success

Link
In Vivo

19 Mar 2019

Device/Diagnostics Quarterly Dealmaking Statistics, Q4 2018

Link
Medtech Insight

19 Mar 2019

DATA: ACC Results Recap Part I: Low-Risk TAVR Trials Bring Good News For Edwards And Medtronic; Apple Watch Detects AFib In Apple Heart Study

Link
Medtech Insight

19 Mar 2019

FDA Focusing More On Safety Of Device Biomaterials, Attorney Warns

Link
Pink Sheet

19 Mar 2019

Clinical Trials: US FDA Should Frame Risk-Based Monitoring As Best Practice, ACRO Says

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Meddevicetracker's Real-time Device Market Data API Solution

Pharma R&D Annual Review 2019

Citeline: Global Clinical Trial Intelligence Solutions

Primal Pictures: 3D Functional Anatomy

Pharma R&D Annual Review 2019 Infographic

Meddevicetracker API Infographic

With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives

Drug-Coating Safety Risk Acknowledged At Cardiology Gathering, But Cause Remains Elusive

Bayer Bosses Beg Risk-Averse Europe To Rethink

Asia Deal Watch: Bharat Expands Its Vaccine Holdings By Buying GSKs Chiron Behring

Targeted Omega-3 Supplementation Could Save Up To €64.5bn In Healthcare Costs, Food Supplements Europe Claims

4C Medical Plans First Early Feasibility Study For An Implantable In Japan

Two New Categories Join GGB Awards In 2019

US Bill Aims To Increase Transparency On Biologics

From STEP to PrEP

Latest headlines

Warning Letter Roundup & Recap – March 19, 2019

Hong Kong Clarifies Rules On Local Responsible Persons To Facilitate Device Listings

‘Keep Planning For No-Deal Brexit,’ UK Govt Tells Pharma As Chaos Grows

Zulresso Is Sage’s First Step In Postpartum Depression Treatment

Merck KGaA Interview: China E-Health Push A ‘Long-Term Strategy’

US FDA “Enriches” Trial Guidance With Recent Examples

PureTech’s Karuna Gets Another $68m For Re-engineered Lilly CNS Candidate

EU MDR: Swiss Medtechs Count The Cost Of Being Without An MRA

AbbVie's 'Unjustified' Humira Settlements Divide Market, Class Action Claims

Gottlieb Touts US FDA's Organizational Structure For Advancing Policies During His Tenure

Urovant’s Vibegron Faces Tough Commercial Climb Despite Phase III Success

Device/Diagnostics Quarterly Dealmaking Statistics, Q4 2018

DATA: ACC Results Recap Part I: Low-Risk TAVR Trials Bring Good News For Edwards And Medtronic; Apple Watch Detects AFib In Apple Heart Study

FDA Focusing More On Safety Of Device Biomaterials, Attorney Warns

Clinical Trials: US FDA Should Frame Risk-Based Monitoring As Best Practice, ACRO Says

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store